NUPAVLI Trademark

Trademark Overview


On Friday, September 29, 2017, a trademark application was filed for NUPAVLI with the United States Patent and Trademark Office. The USPTO has given the NUPAVLI trademark a serial number of 79225448. The federal status of this trademark filing is Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED as of Monday, March 24, 2025. This trademark is owned by Astellas Pharma Inc.. The NUPAVLI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, oncological, ophthalmological, peripheral nervous system, psychiatric, renal, respiratory, urogenital, urological, osteopathic, hematological, pulmonary and viral diseases and disorders; pharmaceutical preparations for the treatment pain and diabetes; pharmaceutical preparations for use in regenerative medicine; pharmaceutical preparations, namely, antibacterial preparations, antifungal preparations, antiviral preparations, dermatological preparations, immunosuppressants, and tissue repair preparations; vaccines
nupavli

General Information


Serial Number79225448
Word MarkNUPAVLI
Filing DateFriday, September 29, 2017
Status739 - Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateMonday, March 24, 2025
Registration Number5472346
Registration DateTuesday, May 22, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 6, 2018

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, oncological, ophthalmological, peripheral nervous system, psychiatric, renal, respiratory, urogenital, urological, osteopathic, hematological, pulmonary and viral diseases and disorders; pharmaceutical preparations for the treatment pain and diabetes; pharmaceutical preparations for use in regenerative medicine; pharmaceutical preparations, namely, antibacterial preparations, antifungal preparations, antiviral preparations, dermatological preparations, immunosuppressants, and tissue repair preparations; vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 29, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAstellas Pharma Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressChuo-ku; Tokyo 103-8411
JP

Party NameAstellas Pharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP

Party NameAstellas Pharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Monday, January 29, 2018ASSIGNED TO EXAMINER
Thursday, January 25, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, January 26, 2018LIMITATION FROM ORIGINAL APPLICATION ENTERED
Monday, January 29, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 29, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 2, 2018APPLICATION FILING RECEIPT MAILED
Friday, June 3, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 14, 2018NOTICE OF PUBLICATION
Tuesday, March 6, 2018PUBLISHED FOR OPPOSITION
Tuesday, May 22, 2018REGISTERED-PRINCIPAL REGISTER
Thursday, June 21, 2018GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Thursday, June 28, 2018FINAL DISPOSITION PROCESSED
Thursday, June 28, 2018FINAL DISPOSITION NOTICE SENT TO IB
Friday, July 13, 2018NOTIFICATION PROCESSED BY IB
Friday, July 30, 2021NEW REPRESENTATIVE AT IB RECEIVED
Friday, June 3, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, June 3, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, June 3, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, June 3, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, June 25, 2022NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, July 9, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 9, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 3, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 9, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 9, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, July 9, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, October 25, 2024TEAS SECTION 71 & 15 RECEIVED
Monday, March 17, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, March 24, 2025REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Monday, March 24, 2025NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Monday, April 14, 2025TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, April 14, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, April 14, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 14, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 14, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED